ASKLEPIOS Course on Radiomics and Imaging Biomarkers in Oncologic Imaging

December 12-13, 2019; Heidelberg/Germany
Course informationThis course aims to familiarise radiology residents in their final years of training and board-certified radiologists with cutting-edge clinical and quantitative imaging technology using CT, MRI and hybrid imaging. The two-day course addresses the development of imaging biomarkers and radiomics in clinical practice, focusing on the precise and accurate analysis of tumours and their heterogeneity. The range of topics covers the currently most challenging areas of oncologic imaging, such as the management of patients suffering from tumours of the liver, pancreas, colo-rectum, lung, pelvis, prostate and brain as well as lymphoma. The course focuses on the clinical needs, technical solutions and practical implementation of quantitative imaging in primary diagnosis, staging, treatment decision-making, therapy response assessment, complications and follow-up surveillance. Also, the main aspects of validating and reporting imaging data are addressed. A unique group of European faculty members, well known for their experience in applying novel imaging biomarkers, offers top quality didactic lectures sharing their expertise and best cases. The combination of didactic lectures with interactive workshops guarantees the high educational value of this teaching program.

Learning objectives

  • to become familiar with the latest technical and methodological advances in imaging biomarkers and radiomics for oncologic imaging
  • to understand different imaging biomarkers and radiomics readouts as spatially and temporally resolved surrogate indicators representing “virtual biopsies” in different tumours
  • to critically evaluate the diagnostic and prognostic value provided by imaging biomarkers related to the individual setting

Thursday, December 12
12:30-12:45 Welcome and introduction
  General concepts
Imaging biomarkers and radiomics: how does it work
E. Sala, Cambridge/UK
13:05-13:25 RECIST and radiomics metrics in therapy response
L. Fournier, Paris/FR
Integrating imaging biomarkers into structured reports
T. Weber, Heidelberg/DE
CT vs. MRI for hepatic and pancreatic imaging biomarkers
N. Kartalis, Stockholm/SE
14:05-14:30 Coffee break
14:30-15:00 Imaging biomarkers and radiomics in gynaecological tumours
E. Sala, Cambridge/UK
15:00-15:30 Colorectal carcinoma and liver metastases
L. Fournier, Paris/FR
15:30-16:00 Imaging biomarkers and radiomics in pancreatic tumours
N. Kartalis, Stockholm/SE
16:00-17:30 Workshops
E. Sala, L. Fournier, N. Kartalis
Closing remarks
Friday, December 13
09:00-09:20    Imaging biomarkers derived from whole body MRI
H.-P. Schlemmer, Heidelberg/DE
09:20-09:40 Imaging biomarkers for lung nodules and lung cancer
H. Prosch, Vienna/AT
Imaging biomarkers for prostate cancer
H.-P. Schlemmer, Heidelberg/DE
Imaging biomarkers for lymphoma
F. Giesel, Heidelberg/DE
10:20-10:50 Coffee break
10:50-12:30 Workshops
H. Prosch, H-P. Schlemmer, F. Giesel
12:30-13:30 Lunch break
13:30-13:50 Imaging biomarkers derived from hybrid imaging
F. Giesel, Heidelberg/DE
13:50-14:10 Complications of immunotherapy
H. Prosch, Vienna/AT
How to use and improve LIRADS in HCC
T. Weber, Heidelberg/DE
Imaging biomarkers and radiomics in glioma
P. Kickingereder, Heidelberg/DE
Coffee break
15:20-17:00 Workshops
H. Prosch, T. Weber, P. Kickingereder
Closing remarks and certificate of attendance
Back to overview

About ESOR

... an established and growing institution, fulfilling the mission of the European Society of Radiology (ESR) in the field of education.

                     Anastas Doreski, Skopje/MK

            Enrique F. Garces-Inigo, Albacete/ES

         Bruno Hochhegger, Porto Alegre/BR

            Saulius Rutkauskas, Kaunas/LT
ESR Contact
  • ESR Office:
  • Am Gestade 1
  • 1010 Vienna, Austria
  • Tel: +43-1-533 40 64
  • Fax: +43-1-533 40 64-448
The European School
of Radiology (ESOR)
is an initiative of the
European Society of